China Emerging As Big Winner In Pharma Outsourcing Rush To Asia -- PwC
This article was originally published in The Pink Sheet Daily
Executive Summary
Asia's expanding wealth and markets for drugs, combined with a pool of scientific talent and strengthening protections for patents, propel pharmaceutical multinationals to step up operations in the region.
You may also be interested in...
Focused On Globalization, Shanghai FDA Will Hold International Forum On Drug Safety And Regulatory Change
BEIJING - In an effort to fast-forward the globalization of China's drug laws and utlimately boost its exports of pharmaceuticals, the Shanghai FDA is partnering with a U.S.-based law firm to co-host its first international forum on drug safety and regulatory change
U.S. FDA Triples Estimate On Deaths Following Allergic Reaction To Blood Thinner Heparin
BEIJING - U.S. FDA last week issued a sharply higher estimate on the number of deaths that have occurred in patients who suffered allergic reactions to the blood thinner heparin
Lilly, Merck Deals Mark Start Of New Era For Indian Drug Firms – PharmAsia News Spotlight
MUMBAI - A new patent law to protect intellectual property and in-depth experience in clinical trials and manufacturing has helped Indian drug firms such as Piramal Healthcare become equal partners with multinational counterparts in sharing risks, costs and profits, according to a senior company executive